Prostatis Group LLC lifted its stake in shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report) by 104.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,539 shares of the company’s stock after purchasing an additional 16,638 shares during the period. Prostatis Group LLC owned approximately 0.12% of Goldman Sachs ActiveBeta Emerging Markets Equity ETF worth $1,211,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the stock. LPL Financial LLC raised its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 14.9% in the 1st quarter. LPL Financial LLC now owns 1,810,975 shares of the company’s stock worth $60,088,000 after purchasing an additional 234,557 shares during the last quarter. Baird Financial Group Inc. boosted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 38.4% in the 1st quarter. Baird Financial Group Inc. now owns 40,669 shares of the company’s stock valued at $1,349,000 after buying an additional 11,279 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 9.2% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 102,515 shares of the company’s stock valued at $3,401,000 after buying an additional 8,621 shares during the last quarter. Comerica Bank boosted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 27.9% in the 1st quarter. Comerica Bank now owns 11,941 shares of the company’s stock valued at $396,000 after buying an additional 2,602 shares during the last quarter. Finally, Atria Wealth Solutions Inc. boosted its position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF by 22.9% in the 1st quarter. Atria Wealth Solutions Inc. now owns 31,198 shares of the company’s stock valued at $1,035,000 after buying an additional 5,812 shares during the last quarter.
Goldman Sachs ActiveBeta Emerging Markets Equity ETF Stock Down 3.5%
Goldman Sachs ActiveBeta Emerging Markets Equity ETF stock opened at $39.72 on Friday. The business’s 50-day simple moving average is $39.51 and its 200 day simple moving average is $36.60. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of 13.33 and a beta of 0.72. Goldman Sachs ActiveBeta Emerging Markets Equity ETF has a 12-month low of $29.19 and a 12-month high of $41.62.
About Goldman Sachs ActiveBeta Emerging Markets Equity ETF
The Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of emerging market stocks comprising 4 sub-indexes: value, momentum, quality, and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight.
Recommended Stories
- Five stocks we like better than Goldman Sachs ActiveBeta Emerging Markets Equity ETF
- How to invest in marijuana stocks in 7 stepsĀ
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- What Investors Need to Know to Beat the Market
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- Trading Halts Explained
- Catch the Next Bitcoin Rally With These 3 ETFs
Want to see what other hedge funds are holding GEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Goldman Sachs ActiveBeta Emerging Markets Equity ETF (NYSEARCA:GEM – Free Report).
Receive News & Ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs ActiveBeta Emerging Markets Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.